This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA338311; GEO: GSE85390 |
| Type | Umbrella project |
| Publications | Mohammad F et al., "EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.", Nat Med, 2017 Apr;23(4):483-492 |
| Submission | Registration date: 9-Aug-2016
BRIC |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 38 |
| Publications |
| PubMed | 1 |
| Other datasets |
| BioSample | 38 |
| GEO DataSets | 5 |
EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas encompasses the following 4 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA338318 | Homo sapiens | EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas [ChIP-Seq human cell lines] (BRIC) | | PRJNA338319 | Mus musculus | EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas [ChIP-Seq mouse cell lines] (BRIC) |
|
| Transcriptome or Gene expression | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA338317 | Mus musculus | EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas [RNA-Seq mouse tumors] (BRIC) | | PRJNA338320 | Mus musculus | EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas [RNA-Seq - mouse cell lines] (BRIC) |
|